GREAT POINT PARTNERS LLC (Mr. David Kroin, Dr. Jeffrey R. Jay, Ortav Yehudai, Lillian Nordahl) - Significant Ownership

Notable people
Mr. David Kroin, Dr. Jeffrey R. Jay, Ortav Yehudai, Lillian Nordahl
Signature - Title
Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GREAT POINT PARTNERS LLC.

Significant Ownership of GREAT POINT PARTNERS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 9.99% $6.77M 11.5M Great Point Partners, LLC Dec 31, 2024
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 9.99% $2.63M 3.33M Great Point Partners, LLC Dec 31, 2024
OPTN OPTINOSE, INC. Common Stock, $0.001 par value per share 8.47% $4.84M 897K Great Point Partners, LLC Dec 31, 2024
OTLK Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share 8.18% $3.29M 2.22M Great Point Partners, LLC Dec 31, 2024
VTGN Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share 6.88% $5.74M 2.06M Great Point Partners, LLC Dec 31, 2024
CNTX Context Therapeutics Inc. Common Stock 6.25% $3.04M 4.68M Great Point Partners, LLC Dec 31, 2024
ZURA ZURA BIO LIMITED Class A Ordinary Shares, $0.0001 par value 4.86% $4.06M 3.17M Great Point Partners, LLC Dec 31, 2024
NGNE NEUROGENE INC. Common Stock, par value $0.000001 per share 2.98% $7.44M 443K Great Point Partners, LLC Dec 31, 2024

Schedules 13D/G Reported by GREAT POINT PARTNERS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.